B. Merinero et al., VARIABLE CLINICAL AND BIOCHEMICAL PRESENTATION OF 7 SPANISH CASES WITH GLUTARYL-COA-DEHYDROGENASE DEFICIENCY, Neuropediatrics, 26(5), 1995, pp. 238-242
In this report, we describe seven new patients with a severe deficienc
y of glutaryl-CoA dehydrogenase in cultured skin fibroblasts. Three of
the patients studied excreted high levels of glutaric acid. The remai
ning four patients presented a lack of significant glutaric aciduria.
However, glutaric acid was found in increased levels in CSE In both gr
oups of patients, the urine glutaric acid levels were not related to t
heir metabolic condition at the time of sampling. Hypocarnitinemia was
a common finding. Some patients also showed defects an respiratory ch
ain complexes Abbreviations In muscle biopsy. Only one patient has a n
ormal psychomotor development. The other six patients are severely han
dicapped despite the attempts of different therapies. In patients with
progressive neurological deterioration with dystonia and cerebellar s
igns associated with temporal lobe atrophy and bilateral basal ganglia
damage on MRI, a glutaric aciduria type I (GA I) should always be inv
estigated. The presence of glutaric acid in body fluids, especially in
CSF, as well as plasma carnitine levels, should be determined. These
procedures can lead to the diagnosis of glutaric aciduria type I.